speb/financial-data huggingface dataset:
Stock screener scorecard for GANESHCP.NS (annual, report date 2026-03-31)
Altman Z-score: 8.055195966339635 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 16.506445640232222%
Earnings yield: 0.11160890659623493%
Return on net tangible assets: 5.817467676816455%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.691070735167592%
Free cash flow margin: 4.103527826227558%
Revenue growth: -7.114676985447462%
Rule of 40 score: -3.0111491592199036
Market cap: 6944560128 (Mid Cap ($2B-$10B))
P/E ratio: 0.1629770292113224
Debt to equity: 0.0717
Free cash flow (dilution adjusted): 3789571.8524798644
Operating income: 6552119.54217889
Net income: 4491945.739720221
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for HAFN (quarterly, report date 2026-03-31)
Altman Z-score: 2.718142587127833 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 5.511650749521973%
Earnings yield: 2.4867884986545286%
Return on net tangible assets: 4.706729036390909%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.533489033722103%
Free cash flow margin: 15.806543885629495%
Revenue growth: 12.320642584545128%
Rule of 40 score: 28.12718647017462
Market cap: 3823326976 (Mid Cap ($2B-$10B))
P/E ratio: 8.043956043956044
Debt to equity: 0.4035
Free cash flow (dilution adjusted): 82245736.43410853
Operating income: 116707751.9379845
Net income: 139325581.39534885
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for INGR (quarterly, report date 2026-03-31)
Altman Z-score: 2.760703065848814 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.449989602828031%
Earnings yield: 2.9292868447385727%
Return on net tangible assets: 2.812006319115324%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.217561268982108%
Free cash flow margin: -4.296875%
Revenue growth: 1.9920318725099602%
Rule of 40 score: -2.30484312749004
Market cap: 6376532480 (Mid Cap ($2B-$10B))
P/E ratio: 10.569113441372735
Debt to equity: 0.4143
Free cash flow (dilution adjusted): -77000000
Operating income: 214000000
Net income: 144000000
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for MARKSANS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 9.336346349720035 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 5.45654317114263%
Earnings yield: 0.017206300521748655%
Return on net tangible assets: 6.0577241671454995%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.133282860581221%
Revenue growth: 7.958705697049558%
Rule of 40 score: 7.958705697049558
Market cap: 111614230528 (Large Cap ($10B-$200B))
P/E ratio: 0.17933987289262215
Debt to equity: 0.1125
Operating income: 18136286.562102586
Net income: 15793980.500211954
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for MARKSANS.NS (annual, report date 2026-03-31)
Altman Z-score: 10.161844355108412 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 16.010768075074257%
Earnings yield: 0.05048729176022603%
Return on net tangible assets: 13.601158146239028%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.062247061321996%
Free cash flow margin: 10.988370477454966%
Revenue growth: 1.9926257052752003%
Rule of 40 score: 12.980996182730166
Market cap: 111614230528 (Large Cap ($10B-$200B))
P/E ratio: 0.17933987289262215
Debt to equity: 0.1125
Free cash flow (dilution adjusted): 34364137.34633319
Operating income: 53216087.32513777
Net income: 44517168.29164901
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for NURS.V (quarterly, report date 2026-03-31)
Altman Z-score: 9.789048490856988 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 9.799440317438611%
Earnings yield: 1.4935728945611628%
Return on net tangible assets: 8.20605330405453%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.916558644446619%
Free cash flow margin: -20.977197907908625%
Revenue growth: 66.77293564679418%
Rule of 40 score: 45.795737738885556
Market cap: 225394800 (Micro Cap ($50M-$300M))
P/E ratio: 21.103117505995208
Debt to equity: 0.24609999999999999
Free cash flow (dilution adjusted): -5229752
Operating income: 3138650
Net income: 2586742
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for PARR (quarterly, report date 2026-03-31)
Altman Z-score: 1.7802335485784364 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.472358913601731%
Earnings yield: 1.1675326028534334%
Return on net tangible assets: 3.324601178405758%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.0645312920852295%
Free cash flow margin: -4.8048800548320765%
Revenue growth: 0.5796254218967153%
Rule of 40 score: -4.2252546329353615
Market cap: 3880665600 (Mid Cap ($2B-$10B))
P/E ratio: 7.093997734994337
Debt to equity: 0.8748
Free cash flow (dilution adjusted): -87629000
Operating income: 59557000
Net income: 54450000
Long score: 1 | Short score: 8
Recommendation: Short
Stock screener scorecard for RPTECH.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.2979399183752065 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 6.234675989743169%
Earnings yield: 0.02212720387796333%
Return on net tangible assets: 4.598722346276412%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.141030053460413%
Revenue growth: 5.969218992708066%
Rule of 40 score: 5.969218992708066
Market cap: 51391852544 (Large Cap ($10B-$200B))
P/E ratio: 0.08657353380200727
Debt to equity: 0.4865
Operating income: 13406846.121237813
Net income: 9202734.209410768
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for RPTECH.NS (annual, report date 2026-03-31)
Altman Z-score: 4.618751166720475 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 21.547474307410177%
Earnings yield: 0.07647315720008768%
Return on net tangible assets: 14.632122988763891%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 21.223827431555577%
Free cash flow margin: 0.5337600380910573%
Revenue growth: 4.176325510129827%
Rule of 40 score: 4.710085548220884
Market cap: 51391852544 (Large Cap ($10B-$200B))
P/E ratio: 0.08657353380200727
Debt to equity: 0.4865
Free cash flow (dilution adjusted): 8952946.163628656
Operating income: 46334993.64137346
Net income: 29922212.80203476
Long score: 11 | Short score: 1
Recommendation: Long
Stock screener scorecard for VLS.AX (annual, report date 2025-12-31)
Altman Z-score: 5.548000608195836 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 25.967432242818113%
Earnings yield: 8.787583243966976%
Return on net tangible assets: 19.34181268344748%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 24.167912435348907%
Free cash flow margin: 17.00010721561059%
Revenue growth: 26.761433686370662%
Rule of 40 score: 43.76154090198125
Market cap: 137831392 (Micro Cap ($50M-$300M))
P/E ratio: 9.246830723340791
Debt to equity: 0.0426
Free cash flow (dilution adjusted): 10641610.738255033
Operating income: 9439597.315436242
Net income: 7003355.704697987
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for VTS (quarterly, report date 2026-03-31)
Altman Z-score: 1.2429691443026512 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0.7503156986299631%
Earnings yield: 0.7383601075963527%
Return on net tangible assets: -5.220310459378204%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7430981864985394%
Free cash flow margin: 6.3966770508826585%
Revenue growth: 14.994882292732855%
Rule of 40 score: 21.391559343615512
Market cap: 659056320 (Small Cap ($300M-$2B))
Debt to equity: 0.2539
Free cash flow (dilution adjusted): 4312000
Operating income: 5912000
Net income: -42280000
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 0839.HK (annual, report date 2025-08-31)
Altman Z-score: 0.8771152149530115 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 12.72583793662001%
Earnings yield: 3.08427494882387%
Return on net tangible assets: -7.506093973270571%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.552054275579433%
Free cash flow margin: 12.671465435284532%
Revenue growth: 12.060371809708451%
Rule of 40 score: 24.73183724499298
Market cap: 7980891665.249999 (Mid Cap ($2B-$10B))
P/E ratio: 8.16877345470829
Debt to equity: 0.5462601540246863
Free cash flow (dilution adjusted): 119768934.53145058
Operating income: 393324775.3530167
Net income: 125417201.54043646
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 3563.T (annual, report date 2025-09-30)
Altman Z-score: 3.458607354003874 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 17.405562333923292%
Earnings yield: 0.017339932947895553%
Return on net tangible assets: 234.46074695121953%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.503829616337146%
Revenue growth: 14.29419961692068%
Rule of 40 score: 14.29419961692068
Market cap: 879010264461 (Mega Cap (>= $200B))
P/E ratio: 35.719056624039986
Debt to equity: 2.1670746573373902
Operating income: 242880215.34320325
Net income: 165605652.7590848
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6030.T (annual, report date 2024-06-30)
Altman Z-score: 2.9904124563497563 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 9.873055368020552%
Earnings yield: 0.16154443927057593%
Return on net tangible assets: 13.615743589878216%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.628843217401052%
Free cash flow margin: 3.4356307966447432%
Revenue growth: 0.7338459423749316%
Rule of 40 score: 4.169476739019675
Market cap: 37178812860 (Large Cap ($10B-$200B))
P/E ratio: 52.18027733060868
Debt to equity: 0.698732632597154
Free cash flow (dilution adjusted): 4787460.327338354
Operating income: 9271858.858671978
Net income: 4434046.9226460885
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 6966.T (annual, report date 2026-01-31)
Altman Z-score: 2.3943527450060285 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 7.060616038888921%
Earnings yield: 0.04085206626275952%
Return on net tangible assets: -9.922226327694815%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.79678937528206%
Free cash flow margin: -2.132103385258028%
Revenue growth: 2.2239129044272996%
Rule of 40 score: 0.0918095191692716
Market cap: 135965542439.99998 (Large Cap ($10B-$200B))
P/E ratio: 42.837284952741015
Debt to equity: 0.7834597848856655
Free cash flow (dilution adjusted): -30393053.01645338
Operating income: 82599895.53408201
Net income: 20723426.482110213
Long score: 2 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for 8395.HK (annual, report date 2025-03-31)
Altman Z-score: 3.9313799618478527 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 77.48929159802309%
Earnings yield: 0.07522271974489%
Return on net tangible assets: 32.59631861146426%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 29.662235451403774%
Free cash flow margin: 3.113346368602471%
Revenue growth: 61.84059613437607%
Rule of 40 score: 64.95394250297855
Market cap: 396000000 (Small Cap ($300M-$2B))
P/E ratio: 246.26865671641792
Debt to equity: 0.6213024192451085
Free cash flow (dilution adjusted): 397043.70179948583
Operating income: 1511439.5886889459
Net income: 206683.80462724934
Long score: 11 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ABDP.L (annual, report date 2025-08-31)
Altman Z-score: 1.8928353969106768 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 30.90185676392573%
Earnings yield: 15.396814907817353%
Return on net tangible assets: 32.69230769230769%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.238718116415958%
Free cash flow margin: 18.22144725370532%
Revenue growth: 5.840071877807724%
Rule of 40 score: 24.061519131513045
Market cap: 3236665.9373999997 (Nano Cap (< $50M))
P/E ratio: 0.26972216145
Debt to equity: 0.023588277340957822
Free cash flow (dilution adjusted): 28243243.243243244
Operating income: 31486486.486486487
Net income: 16216216.216216216
Long score: 13 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ARGX (annual, report date 2025-12-31)
Altman Z-score: 21.339833299267244 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 18.741497716878744%
Earnings yield: 0.08673644862376514%
Return on net tangible assets: 18.63528648250621%
Capitalized R&D asset: 2606355545.220588
ROCI (R&D adjusted): 14.650466852397614%
Rosenberg metric: 2.2564685617002462
Free cash flow margin: 7.835185032702682%
Revenue growth: 114.1779307887669%
Rule of 40 score: 122.01311582146958
Market cap: 44719067003.8475 (Large Cap ($10B-$200B))
P/E ratio: 34.611343348939855
Debt to equity: 0.006439902707763334
Free cash flow (dilution adjusted): 382862352.9411765
Operating income: 1240723529.4117646
Net income: 1520041176.4705882
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for BNR.DE (annual, report date 2025-12-31)
Altman Z-score: 3.0014898154728558 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 14.35477091214796%
Earnings yield: 6.434297576050165%
Return on net tangible assets: 87.38613555658483%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.527276734873809%
Free cash flow margin: 4.440562897538147%
Revenue growth: 5.527181619195775%
Rule of 40 score: 9.967744516733923
Market cap: 6924722441.120001 (Mid Cap ($2B-$10B))
P/E ratio: 25.675648650797186
Debt to equity: 0.7496665593524353
Free cash flow (dilution adjusted): 792588235.2941177
Operating income: 723176470.5882353
Net income: 317294117.64705884
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for EFOR (annual, report date 2025-12-31)
Altman Z-score: 2.4978047263001355 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 39.95489243580847%
Earnings yield: 10.31394106760789%
Return on net tangible assets: -23.60655737704918%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.079618813403013%
Free cash flow margin: 6.034569390011054%
Revenue growth: -2.90996902212357%
Rule of 40 score: 3.124600367887484
Market cap: 1974970000 (Small Cap ($300M-$2B))
P/E ratio: 17.400616740088108
Debt to equity: 0.6482261640798226
Free cash flow (dilution adjusted): 240200000
Operating income: 230300000
Net income: 113500000
Long score: 8 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for FSS (annual, report date 2025-12-31)
Altman Z-score: 6.382171639200868 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 33.13527063411011%
Earnings yield: 4.596881996225133%
Return on net tangible assets: 78.96124439757448%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.913088806748174%
Free cash flow margin: 9.727126805778491%
Revenue growth: 17.13671770077894%
Rule of 40 score: 26.863844506557434
Market cap: 6606544324.8 (Mid Cap ($2B-$10B))
P/E ratio: 26.790528486618005
Debt to equity: 0.430246020260492
Free cash flow (dilution adjusted): 212100000
Operating income: 356900000
Net income: 246600000
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for FTAI (annual, report date 2025-12-31)
Altman Z-score: 4.703753014451553 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 22.74442515283358%
Earnings yield: 3.0501916096269577%
Return on net tangible assets: 97.69434243537069%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.373343402410185%
Free cash flow margin: -40.639121898342076%
Revenue growth: 44.527497534441444%
Rule of 40 score: 3.8883756360993686
Market cap: 20125753276.68 (Large Cap ($10B-$200B))
P/E ratio: 40.16603323463669
Debt to equity: 10.320644334987163
Free cash flow (dilution adjusted): -1018989000
Operating income: 769874000
Net income: 501064000
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for GRPN (annual, report date 2025-12-31)
Altman Z-score: -1.9721579074053353 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 100.06951417316753%
Earnings yield: 1.2117941035587942%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.522211401864592%
Free cash flow margin: 2.4276617003262295%
Revenue growth: 1.190725134349933%
Rule of 40 score: 3.6183868346761625
Market cap: 668897887.8 (Small Cap ($300M-$2B))
Debt to equity: -8.247204529370135
Free cash flow (dilution adjusted): 12100000
Operating income: 12956000
Net income: -81697000
Long score: 5 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for HAFN (annual, report date 2025-12-31)
Altman Z-score: 2.6043108411381057 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 12.897406875922146%
Earnings yield: 5.948712269788882%
Return on net tangible assets: 20.22524966688188%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.029358433007026%
Free cash flow margin: 19.87305365814325%
Revenue growth: -15.481817299235493%
Rule of 40 score: 4.391236358907756
Market cap: 3211394753.408 (Mid Cap ($2B-$10B))
P/E ratio: 9.454121070318708
Debt to equity: 0.48204939330447844
Free cash flow (dilution adjusted): 354285156.25
Operating income: 279179687.5
Net income: 265376562.5
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for INGR (annual, report date 2025-12-31)
Altman Z-score: 3.8287029615909955 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 21.993637327677625%
Earnings yield: 14.194721766326634%
Return on net tangible assets: 17.10654936461388%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.757483665096489%
Free cash flow margin: 7.078542734450755%
Revenue growth: -2.8398384925975773%
Rule of 40 score: 4.238704241853178
Market cap: 6791460869.7 (Mid Cap ($2B-$10B))
P/E ratio: 9.227528355570652
Debt to equity: 0.45144296839212095
Free cash flow (dilution adjusted): 511000000
Operating income: 1037000000
Net income: 736000000
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for JET2.L (annual, report date 2025-03-31)
Altman Z-score: 2.016155034572113 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 16.19925262126764%
Earnings yield: 78.86425685241929%
Return on net tangible assets: 21.48895899053628%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.796921988324787%
Free cash flow margin: 9.003972956018679%
Revenue growth: 17.657421311922306%
Rule of 40 score: 26.661394267940985
Market cap: 22086227.905 (Nano Cap (< $50M))
P/E ratio: 0.04943202306401075
Debt to equity: 0.7059808909293959
Free cash flow (dilution adjusted): 838831168.8311688
Operating income: 579870129.8701298
Net income: 580259740.2597402
Long score: 11 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for NURS.V (annual, report date 2025-12-31)
Altman Z-score: 9.425086486902785 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 14.103045733034156%
Earnings yield: 1.0529264197367683%
Return on net tangible assets: 12.49205327521582%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.765880426459923%
Free cash flow margin: -9.788592003207683%
Revenue growth: 120.54013296340054%
Rule of 40 score: 110.75154096019286
Market cap: 185282834.96350366 (Micro Cap ($50M-$300M))
P/E ratio: 109.35631088842597
Debt to equity: 0.4242168459170726
Free cash flow (dilution adjusted): -3463697
Operating income: 2212659
Net income: 1694304
Long score: 8 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for PARR (annual, report date 2025-12-31)
Altman Z-score: 3.2566448049241465 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 22.555427541527227%
Earnings yield: 9.989905078346716%
Return on net tangible assets: 26.538282488834575%
Capitalized R&D asset: 3761010
ROCI (R&D adjusted): 18.51841268152101%
Free cash flow margin: 3.7492045842738775%
Revenue growth: -6.392999548433203%
Rule of 40 score: -2.643794964159326
Market cap: 1762069893.78 (Small Cap ($300M-$2B))
P/E ratio: 4.7702025598349715
Debt to equity: 0.7902527252537171
Free cash flow (dilution adjusted): 279865000
Operating income: 509595000
Net income: 369391000
Long score: 13 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for VTS (annual, report date 2025-12-31)
Altman Z-score: 2.107370297694049 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 2.051460778043657%
Earnings yield: 2.1392710221613545%
Return on net tangible assets: 4.294497049976402%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.0340838784988464%
Free cash flow margin: 11.840256360656815%
Revenue growth: 13.21953073992347%
Rule of 40 score: 25.059787100580287
Market cap: 765422980.4000001 (Small Cap ($300M-$2B))
P/E ratio: 30.281401289710015
Debt to equity: 0.20921729430477803
Free cash flow (dilution adjusted): 32441000
Operating income: 17129000
Net income: 25277000
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 0062.HK (annual, report date 2025-12-31)
Altman Z-score: 1.603410268082727 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.992649457767834%
Earnings yield: 0.9033237001809772%
Return on net tangible assets: 6.386894119158672%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.49664111566615%
Free cash flow margin: 12.677103660251873%
Revenue growth: 2.5034631714659747%
Rule of 40 score: 15.180566831717847
Market cap: 5079686144 (Mid Cap ($2B-$10B))
P/E ratio: 1.6893132574366503
Debt to equity: 0.1968
Free cash flow (dilution adjusted): 137569794.344473
Operating income: 61503341.90231362
Net income: 51159640.102827765
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0819.HK (annual, report date 2025-12-31)
Altman Z-score: 1.5786354054055654 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 10.66385026471331%
Earnings yield: 2.63310071849524%
Return on net tangible assets: 8.318037184455687%
Capitalized R&D asset: 515733500.4610788
ROCI (R&D adjusted): 7.218148658596419%
Rosenberg metric: 0.17394960578616878
Free cash flow margin: 6.836416221415961%
Revenue growth: -30.009867929508182%
Rule of 40 score: -23.173451708092223
Market cap: 5427920384 (Mid Cap ($2B-$10B))
P/E ratio: 0.5766692142013478
Debt to equity: 0.6727
Free cash flow (dilution adjusted): 472739974.2930591
Operating income: 268301156.81233934
Net income: 213747043.70179948
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0894.HK (annual, report date 2025-12-31)
Altman Z-score: 1.4330057289000713 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 7.9377764352087725%
Earnings yield: 0.4454859207946551%
Return on net tangible assets: -2.0852293275363936%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.098850135846474%
Free cash flow margin: -3.9799106845135963%
Revenue growth: 2.0865275165948636%
Rule of 40 score: -1.8933831679187327
Market cap: 1035336576 (Small Cap ($300M-$2B))
P/E ratio: 9.768637532133676
Debt to equity: 0.7497
Free cash flow (dilution adjusted): -8437789.203084832
Operating income: 9051799.485861182
Net income: 803341.9023136246
Long score: 2 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for 2767.T (annual, report date 2026-03-31)
Altman Z-score: 4.938748075158194 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 27.700342900685804%
Earnings yield: 0.14554235287653566%
Return on net tangible assets: 23.427021197721828%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 22.215290597746513%
Free cash flow margin: 3.0699084655051627%
Revenue growth: 15.952756983728445%
Rule of 40 score: 19.022665449233607
Market cap: 91822358528 (Large Cap ($10B-$200B))
P/E ratio: 0.04217499197418876
Debt to equity: 0.1374
Free cash flow (dilution adjusted): 33445945.945945945
Operating income: 109165415.4154154
Net income: 82488738.73873873
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 6902.T (annual, report date 2026-03-31)
Altman Z-score: 2.377432945937066 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.31084106104748%
Earnings yield: 0.006732407720522494%
Return on net tangible assets: 14.07988175683835%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.8309063116003904%
Free cash flow margin: 1.9808969103979044%
Revenue growth: -2.735800148310068%
Rule of 40 score: -0.7549032379121636
Market cap: 4956413755392 (Mega Cap (>= $200B))
P/E ratio: 0.04722503511263201
Debt to equity: 0.1493
Free cash flow (dilution adjusted): 480705705.7057057
Operating income: 350713213.2132132
Net income: 4392774024.024024
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 8086.T (annual, report date 2026-03-31)
Altman Z-score: 1.1185714799046798 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 5.625234540509911%
Earnings yield: 0.027308802999682805%
Return on net tangible assets: 32.89419847396889%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.7945022191695985%
Free cash flow margin: 8.274618568500221%
Revenue growth: -4.0773611044684275%
Rule of 40 score: 4.197257464031794
Market cap: 256060375040 (Mega Cap (>= $200B))
P/E ratio: 0.13242921044339487
Debt to equity: 1.9149
Free cash flow (dilution adjusted): 341948198.1981982
Operating income: 235391641.64164165
Net income: 98529779.77977978
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 9311.T (annual, report date 2026-03-31)
Altman Z-score: 1.8911388483823144 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 9.503418103316287%
Earnings yield: 0.1319093191376361%
Return on net tangible assets: 10.412136496086204%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.261900710767653%
Free cash flow margin: 6.637097420829408%
Revenue growth: -5.962926988349927%
Rule of 40 score: 0.6741704324794808
Market cap: 11358684160 (Large Cap ($10B-$200B))
P/E ratio: 0.0422350712240316
Debt to equity: 0.3482
Free cash flow (dilution adjusted): 16245226.476476476
Operating income: 16154517.017017016
Net income: 11159559.55955956
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for 9989.HK (quarterly, report date 2026-03-31)
Altman Z-score: 1.6350933142779167 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 2.7265341566866907%
Earnings yield: 0.4686378542223285%
Return on net tangible assets: 1.7337828645695563%
Capitalized R&D asset: 10090591.207054641
ROCI (R&D adjusted): 1.6673768297267708%
Rosenberg metric: 0.7914027900983004
Free cash flow margin: 26.72012210583415%
Revenue growth: 4.955883016607768%
Rule of 40 score: 31.676005122441918
Market cap: 6456103424 (Mid Cap ($2B-$10B))
P/E ratio: 1.9897959183673468
Debt to equity: 0.2668
Free cash flow (dilution adjusted): 51462072.814761214
Operating income: 29351588.118668597
Net income: 27144952.4211288
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AGCC (annual, report date 2025-12-31)
Altman Z-score: 347.92595274497836 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 7.88473150063015%
Earnings yield: 0.007367255854809678%
Return on net tangible assets: 6.904240632027597%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.845011912670236%
Free cash flow margin: -120.82175213150508%
Revenue growth: 156.4539879239373%
Rule of 40 score: 35.63223579243221
Market cap: 339746720 (Small Cap ($300M-$2B))
P/E ratio: 244
Debt to equity: 1.6958000000000002
Free cash flow (dilution adjusted): -240026.0243277849
Operating income: 25096.959026888606
Net income: 19506.466069142127
Long score: 2 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for AKO.A (quarterly, report date 2026-03-31)
Altman Z-score: 1.9874098646410583 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 8.885630100222322%
Earnings yield: 3.5884233818144247%
Return on net tangible assets: 9.826275520488023%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.06957893585662%
Free cash flow margin: 3.831586409314091%
Revenue growth: -6.04200581432228%
Rule of 40 score: -2.2104194050081896
Market cap: 3565415936 (Mid Cap ($2B-$10B))
P/E ratio: 11.502673796791443
Debt to equity: 0.8253
Free cash flow (dilution adjusted): 38070493.00165552
Operating income: 158370591.9029907
Net income: 107887084.77564447
Long score: 4 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for BLUESTONE.NS (annual, report date 2026-03-31)
Altman Z-score: 2.3935828835774715 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 6.990227011287307%
Earnings yield: 0.014750404211999425%
Return on net tangible assets: 8.154893820541838%
Capitalized R&D asset: 250053.52731430915
ROCI (R&D adjusted): 6.281385220439583%
Rosenberg metric: 104.89200843474083
Free cash flow margin: -16.03801308803394%
Revenue growth: 24.784437451238357%
Rule of 40 score: 8.746424363204419
Market cap: 75586265088 (Large Cap ($10B-$200B))
P/E ratio: 4.649794758069332
Debt to equity: 1.1003
Free cash flow (dilution adjusted): -41410979.22848665
Operating income: 19029885.54472234
Net income: 1396672.3187791437
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for CABKA.AS (annual, report date 2025-12-31)
Altman Z-score: 1.1978149591351182 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0.46477975080937894%
Earnings yield: 0.39622569992736717%
Capitalized R&D asset: 75375
ROCI (R&D adjusted): 0.3925240633011132%
Rosenberg metric: 95.4908496732027
Free cash flow margin: 3.94518548012476%
Revenue growth: 12.295329903135945%
Rule of 40 score: 16.240515383260707
Market cap: 50112924 (Micro Cap ($50M-$300M))
Debt to equity: 1.2975999999999999
Free cash flow (dilution adjusted): 8392941.176470589
Operating income: 445882.3529411765
Net income: -8698823.529411765
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for CHENNPETRO.NS (annual, report date 2026-03-31)
Altman Z-score: 5.227280647023191 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 34.60366782174376%
Earnings yield: 0.22505996354178556%
Return on net tangible assets: 25.39717510196305%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 32.37856778140561%
Free cash flow margin: 3.208513631193936%
Revenue growth: -2.8042843882960544%
Rule of 40 score: 0.40422924289788176
Market cap: 163340910592 (Large Cap ($10B-$200B))
P/E ratio: 0.04859897030036032
Debt to equity: 0.17679999999999998
Free cash flow (dilution adjusted): 216394658.7537092
Operating income: 439505086.9012293
Net income: 328815175.9220008
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for CWY.AX (annual, report date 2025-06-30)
Altman Z-score: 1.5550670129466453 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 13.374512638542079%
Earnings yield: 2.6268099543199237%
Return on net tangible assets: -727.3209549071619%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.513119164996298%
Free cash flow margin: 3.22257119480588%
Revenue growth: 0.38395425189857724%
Rule of 40 score: 3.6065254467044574
Market cap: 5289254912 (Mid Cap ($2B-$10B))
P/E ratio: 34.64052287581699
Debt to equity: 0.7954000000000001
Free cash flow (dilution adjusted): 79803921.56862745
Operating income: 199542483.6601307
Net income: 103594771.24183007
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for DPM.TO (quarterly, report date 2026-03-31)
Altman Z-score: 15.035736277067564 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 6.2170032682477165%
Earnings yield: 1.2013193056899691%
Return on net tangible assets: 6.9334933214134296%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.1493402122430645%
Free cash flow margin: 48.48532690647111%
Revenue growth: -13.204080498688583%
Rule of 40 score: 35.281246407782525
Market cap: 11593650176 (Large Cap ($10B-$200B))
P/E ratio: 9.80341075329152
Debt to equity: 0
Free cash flow (dilution adjusted): 108259712.23021583
Operating income: 132363309.35251799
Net income: 119361151.0791367
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for DVN (quarterly, report date 2026-03-31)
Altman Z-score: 2.408394892936677 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.2028683784408976%
Earnings yield: 0.8934745239347804%
Return on net tangible assets: 5.696763202725724%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.121938940630731%
Free cash flow margin: 15.865510900971893%
Revenue growth: -7.61950982771172%
Rule of 40 score: 8.246001073260173
Market cap: 51949277184 (Large Cap ($10B-$200B))
P/E ratio: 13.916434540389973
Debt to equity: 0.5636
Free cash flow (dilution adjusted): 604000000
Operating income: 312000000
Net income: 120000000
Long score: 5 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for ENOG.L (quarterly, report date 2026-03-31)
Altman Z-score: 0.4901560924872689 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 1.7582466391121605%
Earnings yield: 1.8902167786304367%
Return on net tangible assets: -2.8299949708817023%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.1304521348966867%
Free cash flow margin: 46.679953844540016%
Revenue growth: -68.39633095184897%
Rule of 40 score: -21.71637710730895
Market cap: 1529448064 (Small Cap ($300M-$2B))
P/E ratio: 0.16621636876420814
Debt to equity: 25.601300000000002
Free cash flow (dilution adjusted): 111250000
Operating income: 92714473.68421052
Net income: 31255263.157894738
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for HDD.DE (annual, report date 2026-03-31)
Altman Z-score: 1.566612393165049 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 6.978798586572438%
Earnings yield: 24.445144239817505%
Return on net tangible assets: 8.235294117647058%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.975794251134644%
Free cash flow margin: -1.264718709114697%
Revenue growth: 6.350070578745702%
Rule of 40 score: 5.085351869631005
Market cap: 411462720 (Small Cap ($300M-$2B))
P/E ratio: 30.804597701149426
Debt to equity: 0.1778
Free cash flow (dilution adjusted): -33333333.333333332
Operating income: 90804597.70114942
Net income: 17241379.310344826
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for HDD.DE (quarterly, report date 2026-03-31)
Altman Z-score: 0.710044799684704 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 2.0318021201413425%
Earnings yield: 7.116940728048135%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.739788199697428%
Free cash flow margin: 7.670043415340087%
Revenue growth: 9.41895340822294%
Rule of 40 score: 17.08899682356303
Market cap: 411462720 (Small Cap ($300M-$2B))
P/E ratio: 30.804597701149426
Debt to equity: 0.1778
Free cash flow (dilution adjusted): 60919540.22988506
Operating income: 26436781.609195404
Net income: -2298850.574712644
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for JBS (quarterly, report date 2026-03-31)
Altman Z-score: 1.2617300420719815 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 2.2980785385613425%
Earnings yield: 1.6321003535910126%
Return on net tangible assets: 69.97645921302778%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.4847450598182872%
Free cash flow margin: -6.325210419450567%
Revenue growth: -8.460102230274934%
Rule of 40 score: -14.785312649725501
Market cap: 40389476352 (Large Cap ($10B-$200B))
P/E ratio: 10.26543209876543
Debt to equity: 2.6823
Free cash flow (dilution adjusted): -1571024137.9310346
Operating income: 571025287.3563218
Net income: 277689655.17241377
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for KAYNES.NS (annual, report date 2026-03-31)
Altman Z-score: 7.111894051702351 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 12.6605384701306%
Earnings yield: 0.022617913518492357%
Return on net tangible assets: -18.265507660376937%
Capitalized R&D asset: 100520.08819179484
ROCI (R&D adjusted): 9.024424365272395%
Rosenberg metric: 365.201164937713
Free cash flow margin: -50.76206018496816%
Revenue growth: 20.782206740233473%
Rule of 40 score: -29.97985344473469
Market cap: 212915470336 (Mega Cap (>= $200B))
P/E ratio: 0.6662649442881204
Debt to equity: 0.1917
Free cash flow (dilution adjusted): -195083933.87028402
Operating income: 49489932.174650274
Net income: 38564010.17380246
Long score: 7 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for KAYNES.NS (quarterly, report date 2026-03-31)
Altman Z-score: 6.609264945151235 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 3.776171715298586%
Earnings yield: 0.006746089472347641%
Return on net tangible assets: 3.4576219035189704%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.69579053329176%
Revenue growth: 47.03292246311318%
Rule of 40 score: 47.03292246311318
Market cap: 212915470336 (Mega Cap (>= $200B))
P/E ratio: 0.6662649442881204
Debt to equity: 0.1917
Operating income: 14761021.619330226
Net income: 9667549.809241204
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for MAMK (annual, report date 2025-10-31)
Altman Z-score: 102.41727835083837 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0.6962638463049978%
Earnings yield: 0.006602319675421995%
Return on net tangible assets: 1.066289603448304%
Capitalized R&D asset: 177632.4442289525
ROCI (R&D adjusted): 0.6834664592062535%
Rosenberg metric: -2.4226917903292735
Free cash flow margin: -18.283597949217487%
Revenue growth: 36.3287751760046%
Rule of 40 score: 18.04517722678711
Market cap: 216124992 (Micro Cap ($50M-$300M))
P/E ratio: 80.83333333333333
Debt to equity: 0.34299999999999997
Free cash flow (dilution adjusted): -751423.6286919831
Operating income: 14567.229254571026
Net income: 2548.8045007032347
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for MULTI.OL (quarterly, report date 2026-03-31)
Altman Z-score: 1.9403711321738975 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 15.999290384712857%
Earnings yield: 0.299598959990394%
Return on net tangible assets: -78.91927664043503%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.9624237909115%
Free cash flow margin: 8.949621646895329%
Revenue growth: 6.194514216834553%
Rule of 40 score: 15.144135863729883
Market cap: 4128845312 (Mid Cap ($2B-$10B))
P/E ratio: 1.9439950431998896
Debt to equity: 1.1032
Free cash flow (dilution adjusted): 16996711.202466596
Operating income: 16220452.209660841
Net income: 11307913.669064747
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for SDI.AX (annual, report date 2024-06-30)
Altman Z-score: 3.836866287428724 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 16.0725943334639%
Earnings yield: 5.068016896254083%
Return on net tangible assets: 17.01939757136098%
Capitalized R&D asset: 1667390.6523559415
ROCI (R&D adjusted): 11.414573628600252%
Rosenberg metric: 6.079212210733636
Free cash flow margin: 3.623905184972034%
Revenue growth: 3.7943288056495534%
Rule of 40 score: 7.418233990621587
Market cap: 166055136 (Micro Cap ($50M-$300M))
P/E ratio: 4.933333333333334
Debt to equity: 0.1602
Free cash flow (dilution adjusted): 2686666.6666666665
Operating income: 9027333.333333334
Net income: 6947333.333333333
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for 276A.T (annual, report date 2025-08-31)
Altman Z-score: 15.823650921447951 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 31.123711826998314%
Earnings yield: 0.020966598341257626%
Return on net tangible assets: 21.226884106086956%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 28.624942913365608%
Free cash flow margin: -19.555460058253356%
Revenue growth: 98.63899796594502%
Rule of 40 score: 79.08353790769166
Market cap: 38896196870 (Large Cap ($10B-$200B))
P/E ratio: 87.26814327285291
Debt to equity: 0.6919441004607394
Free cash flow (dilution adjusted): -3403849.036037877
Operating income: 4176020.1648613666
Net income: 3036371.687444649
Long score: 11 | Short score: 5
Recommendation: Long
Stock screener scorecard for 9989.HK (annual, report date 2025-12-31)
Altman Z-score: 1.299311629089729 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 8.38341753563363%
Earnings yield: 1.4505884916719056%
Return on net tangible assets: 6.420483619051116%
Capitalized R&D asset: 60236509.39555578
ROCI (R&D adjusted): 5.031265312657383%
Rosenberg metric: 0.2902087835706037
Free cash flow margin: 29.053727942398616%
Revenue growth: 8.201206197285734%
Rule of 40 score: 37.25493413968435
Market cap: 988162067.4807196 (Small Cap ($300M-$2B))
P/E ratio: 2.827474060957771
Debt to equity: 0.24614980654221721
Free cash flow (dilution adjusted): 227406935.7042857
Operating income: 90852831.35714285
Net income: 49926544.54
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AKO.A (annual, report date 2025-12-31)
Altman Z-score: 2.43218857952941 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 30.533215047741113%
Earnings yield: 11.236319667482379%
Return on net tangible assets: -2.3849062100411724%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 16.821978966256015%
Free cash flow margin: 5.4802446268087435%
Revenue growth: 14.508343134477213%
Rule of 40 score: 19.988587761285956
Market cap: 1604343763618.2002 (Mega Cap (>= $200B))
P/E ratio: 5.931525793450074
Debt to equity: 0.9697893637963546
Free cash flow (dilution adjusted): 203686009.06727114
Operating income: 502822454.83032197
Net income: 300550497.8109652
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for ALBH.L (annual, report date 2025-12-31)
Altman Z-score: 2.2648479887600588 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 9.799261664652603%
Earnings yield: 8.513648003095945%
Return on net tangible assets: 12.734255412333178%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.764796389029803%
Free cash flow margin: 15.736418158145057%
Revenue growth: 18.5770213473996%
Rule of 40 score: 34.31343950554466
Market cap: 32625739.929599997 (Nano Cap (< $50M))
P/E ratio: 0.14918852396839333
Debt to equity: 0.1817799976697208
Free cash flow (dilution adjusted): 378263513.5135135
Operating income: 315266216.2162162
Net income: 295524324.3243243
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for DPM.TO (annual, report date 2025-12-31)
Altman Z-score: 12.465586067678625 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 15.232684748872932%
Earnings yield: 2.850813903921911%
Return on net tangible assets: 18.622011034976392%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.070141978936045%
Free cash flow margin: 66.39890750051816%
Revenue growth: 63.44661957809805%
Rule of 40 score: 129.84552707861621
Market cap: 9354494604.56 (Mid Cap ($2B-$10B))
P/E ratio: 25.335416803150373
Debt to equity: 0.004829490450267756
Free cash flow (dilution adjusted): 460663503.649635
Operating income: 314107299.270073
Net income: 269508029.19708025
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for DVN (annual, report date 2025-12-31)
Altman Z-score: 2.9534787066709867 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 15.040174740619394%
Earnings yield: 11.042428731706773%
Return on net tangible assets: 40.967851099830796%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.01519281794061%
Free cash flow margin: 15.696997905515476%
Revenue growth: 7.8293601003764115%
Rule of 40 score: 23.526358005891886
Market cap: 41730124411.26 (Large Cap ($10B-$200B))
P/E ratio: 15.565134058657218
Debt to equity: 0.5529366306027821
Free cash flow (dilution adjusted): 2698000000
Operating income: 3856000000
Net income: 2681000000
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ENOG.L (annual, report date 2024-12-31)
Altman Z-score: 0.6194103592507569 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 11.965755237193076%
Earnings yield: 17.73427493812637%
Return on net tangible assets: -45.26999643602668%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.784981989588509%
Free cash flow margin: 19.520482316359384%
Revenue growth: 79.57887751087131%
Rule of 40 score: 99.0993598272307
Market cap: 16846095.460799996 (Nano Cap (< $50M))
P/E ratio: 0.13218118481251026
Debt to equity: 5.762863139520386
Free cash flow (dilution adjusted): 434187500
Operating income: 869860000
Net income: 159308750
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for JBS (annual, report date 2025-12-31)
Altman Z-score: 2.619163913081377 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 19.416603349621393%
Earnings yield: 14.465427987927109%
Return on net tangible assets: 244.99816171630354%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.797636365735016%
Free cash flow margin: 0.924424855595891%
Revenue growth: 26.113263769791022%
Rule of 40 score: 27.037688625386913
Market cap: 8806646324.699999 (Mid Cap ($2B-$10B))
P/E ratio: 3.9495371427917942
Debt to equity: 2.4003312684275016
Free cash flow (dilution adjusted): 937303529.4117646
Operating income: 5061040000
Net income: 2623284705.882353
Long score: 10 | Short score: 3
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for KPN.AS (annual, report date 2025-12-31)
Altman Z-score: 1.1889692474281408 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 22.217061464623004%
Earnings yield: 7.380910248605402%
Return on net tangible assets: 282.08616780045355%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.569739952718676%
Free cash flow margin: 17.923063653613937%
Revenue growth: 16.851686596466166%
Rule of 40 score: 34.7747502500801
Market cap: 14677990747.670002 (Large Cap ($10B-$200B))
P/E ratio: 17.16724064054971
Debt to equity: 1.961246840775063
Free cash flow (dilution adjusted): 1222352941.1764705
Operating income: 1688235294.1176472
Net income: 1005882352.9411765
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for MULTI.OL (annual, report date 2025-12-31)
Altman Z-score: 3.232267014382332 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 43.39145441230889%
Earnings yield: 0.7176475207086179%
Return on net tangible assets: -142.11193290477178%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.104642940585771%
Free cash flow margin: 2.5983482401278177%
Revenue growth: 17.629060792027442%
Rule of 40 score: 20.227409032155258
Market cap: 4737451009.951942 (Mid Cap ($2B-$10B))
P/E ratio: 18.72835991220585
Debt to equity: 1.2522694222260558
Free cash flow (dilution adjusted): 17128557.213930346
Operating income: 38853830.84577114
Net income: 25169751.243781094
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 5950.T (annual, report date 2025-12-31)
Altman Z-score: 1.8104800064200346 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.37926023940983966%
Free cash flow margin: -1.5549492405331728%
Revenue growth: 0.8469109448843848%
Rule of 40 score: -0.7080382956487881
Market cap: 2624431732.482533 (Mid Cap ($2B-$10B))
Debt to equity: 0.8529865175134219
Free cash flow (dilution adjusted): -503484.4319416917
Operating income: 66849.94565564861
Net income: -193011.95575730453
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 6731.T (annual, report date 2025-09-30)
Altman Z-score: 12.059620272277154 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -104.60542493426901%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -89.65000343498252%
Free cash flow margin: -102.85188022722348%
Revenue growth: -17.29950435614468%
Rule of 40 score: -120.15138458336816
Market cap: 7089356999.999999 (Mid Cap ($2B-$10B))
Debt to equity: 0.007418380085875877
Free cash flow (dilution adjusted): -6929205.921938089
Operating income: -5356816.958277254
Net income: -5746292.059219381
Long score: 4 | Short score: 12
Recommendation: Short
Stock screener scorecard for BA (annual, report date 2025-12-31)
Altman Z-score: 1.3450961138233946 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -9.941738870630415%
Capitalized R&D asset: 7283450000
ROCI (R&D adjusted): -8.014921095779718%
Rosenberg metric: 1.6474291710388247
Free cash flow margin: -2.5843085968500943%
Revenue growth: 34.496444517942784%
Rule of 40 score: 31.91213592109269
Market cap: 171156202106.72 (Large Cap ($10B-$200B))
P/E ratio: 76.47730210309204
Debt to equity: 9.974894630749496
Free cash flow (dilution adjusted): -2312000000
Operating income: -5416000000
Net income: 2238000000
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)